ResearcherTohoku UniversityActive in the last 2 years

Kent Miyazaki

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5104330715. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 1 paper

Papers 1

GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthetic pathway in pancreatic cancer. Co-author DOI 10.1007/s10585-024-10298-y ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingyu Xun · 1 shared paper, 2024 · strength 0.20
- Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y ↗
Kei Nakagawa · 1 shared paper, 2024 · strength 0.20
- Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y ↗
Masamichi Mizuma · 1 shared paper, 2024 · strength 0.20
- Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y ↗
Kyohei Ariake · 1 shared paper, 2024 · strength 0.20
- Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y ↗
Daisuke Douchi · 1 shared paper, 2024 · strength 0.20
- Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y ↗
Michiaki Unno · 1 shared paper, 2024 · strength 0.20
- Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.